news
France 24 En
2026-08-26
FDA Approves Revolution Medicines’ Rasonque for Advanced Pancreatic Cancer
The U.S. FDA has approved a new daily pill that has demonstrated the ability to double survival rates in patients with metastatic pancreatic cancer.